Molecular anatomy of adult mouse leptomeninges

Riikka Pietilä, Francesca Del Gaudio, Liqun He, Elisa Vázquez-Liébanas, Michael Vanlandewijck, Lars Muhl, Giuseppe Mocci, Katrine D. Bjørnholm, Caroline Lindblad, Alexander Fletcher-Sandersjöö, Mikael Svensson, Eric P. Thelin, Jianping Liu, A. Jantine van Voorden, Monica Torres, Salli Antila, Li Xin, Helena Karlström, Jon Storm-Mathisen, Linda Hildegard BergersenAldo Moggio, Emil M. Hansson, Maria H. Ulvmar, Per Nilsson, Taija Mäkinen, Maarja Andaloussi Mäe, Kari Alitalo, Steven T. Proulx, Britta Engelhardt, Donald M. McDonald, Urban Lendahl, Johanna Andrae, Christer Betsholtz*

*Corresponding author af dette arbejde

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

52 Citationer (Scopus)
11 Downloads (Pure)

Abstract

Leptomeninges, consisting of the pia mater and arachnoid, form a connective tissue investment and barrier enclosure of the brain. The exact nature of leptomeningeal cells has long been debated. In this study, we identify five molecularly distinct fibroblast-like transcriptomes in cerebral leptomeninges; link them to anatomically distinct cell types of the pia, inner arachnoid, outer arachnoid barrier, and dural border layer; and contrast them to a sixth fibroblast-like transcriptome present in the choroid plexus and median eminence. Newly identified transcriptional markers enabled molecular characterization of cell types responsible for adherence of arachnoid layers to one another and for the arachnoid barrier. These markers also proved useful in identifying the molecular features of leptomeningeal development, injury, and repair that were preserved or changed after traumatic brain injury. Together, the findings highlight the value of identifying fibroblast transcriptional subsets and their cellular locations toward advancing the understanding of leptomeningeal physiology and pathology.

OriginalsprogEngelsk
TidsskriftNeuron
Vol/bind111
Udgave nummer23
Sider (fra-til)3745-3764.e.1-e7
Antal sider28
ISSN0896-6273
DOI
StatusUdgivet - 2023

Bibliografisk note

Funding Information:
We thank Cecilia Olsson, Pia Peterson, Jana Chmielniakova, Helene Leksell, Karin Staxäng, Monika Hodik, and the BioVis core for technical assistance at Uppsala University; Sonja Gustafsson, Byambajav Buyandelger, Elisabeth Raschperger, and the single-cell core at Campus Flemingsberg (SICOF) for technical assistance at Karolinska Institutet; and Karri Niiranen, Tanja Laakkonen, Tapio Tainola, the Flow Cytometry Unit at the Helsinki Institute of Life Sciences (HiLIFE), and the Laboratory Animal Center at HiLIFE for technical assistance at the University of Helsinki. We thank Drs. Mikio Furuse, Lydia Sorokin, and Philippe Soriano for kindly providing LSR antibodies, LAMA1 antibodies, and Pdgfra-H2BGFP mice, respectively. Financial support is acknowledged as follows: Swedish Research Council (C.B. 2015-00550; U.L. 2019:00285; T.M. 2020-02692); Swedish Cancer Society (C.B. 2018/449, 2018/1154, and 211714Pj); Knut and Alice Wallenberg Foundation (C.B. 2020.0057; T.M. 2018.0218); Swedish Brain Foundation (C.B. and U.L. ALZ2019-0130 and ALZ2022-0005; U.L. F2020-0246); Erling-Persson Family Foundation (H.K. U.L. P.N. E.P.T. and C.B.); Stiftelsen för ålderssjukdomar vid KI (F.D.G. 2022:01310); Magn. Bergvalls Foundation (L.M. 2020-03735, 2021-04275, and 2022-158); Wenner-Gren foundations Fellows program (E.M.H.); Strategic Research Area Neuroscience (StratNeuro) (E.P.T.); Karolinska Institutet Funds (E.P.T. 2022-01576); Region Stockholm ALF (E.P.T. FoUI-962566); Region Stockholm Clinical Research Appointment (E.P.T. FoUI-981490); Karolinska Institutet Clinical Scientist Training Program (C.L.); Karolinska Institutet Research Internship (C.L.); Uppsala University Hospital Research Residency Program (C.L.); Strategic Research Area Stem Cells and Regeneration (StratRegen) (M.V.); KI Infrastructure Council (M.V.); The European Research Council (ERC) under the European Union's Horizon 2020 research and innovation programme under grant agreement No 743155 (BrainDrain) (K.A.); Research Council of Finland Terva Program (grant 335721) and the Finnish Brain Foundation (K.A.); Swiss National Science Foundation Grant 310030_189080 (B.E.) and CRSII5_213535 (S.P. and B.E); Research Council of Norway (RCN) Grant 214458 (L.H.B. and J.S.-M.); National Heart Lung and Blood Institute of the US National Institutes of Health (D.M. R01HL143896, R01HL059157, and R01HL127402). Computations/data handling were enabled by the National Academic Infrastructure for Supercomputing in Sweden (NAISS) and the Swedish National Infrastructure for Computing (SNIC) at NAISS AFFILIATED SITE/SNIC CENTRE, partially funded by Swedish Research Council through grant agreements 2022-06725 and 2018-05973. C.B. J.A. and U.L. conceived and designed the project. R.P. performed ISH, immunofluorescence, and reporter mouse analyses. F.D.G. performed reporter and TBI experiments and isolated cells for scRNA-seq analysis. L.H. performed bioinformatic analyses and constructed online databases. E.V.-L. performed immunofluorescence analyses. M.V. L.M. G.M. and J.L. performed scRNA-seq analyses. K.D.B. C.L. A.F.-S. M.S. and E.P.T. performed TBI experiments. A.J.v.V. M.T. and J.A. performed reporter and immunofluorescence analyses. S.A. performed scRNA-seq analysis of the dura mater. L.X. performed analysis of reporter mice. H.K. supervised K.D.B. J.S.-M. and L.H.B. contributed Hcar1 reporter mice at an early stage of the project. A.M. and E.M.H. generated Tcf21-CreERT2 mice. M.H.U. contributed Prox1-GFP mice. M.V. P.N. and H.K. supported scRNA-seq analysis of brain vascular fragments. T.M. contributed Cldn11-CreERT2:Ai14 mice. M.A.M. supervised E.V.-L. K.A. supervised S.A. and S.T.P. supervised L.X. C.B. R.P. L.H. F.D.G. E.V.-L. M.A.M. K.A. S.T.P. B.E. D.M.M. U.L. and J.A. interpreted the data. C.B. L.H. R.P. E.V.-L. and M.A.M. designed illustrations. C.B. U.L. and D.M.M. wrote the manuscript. All authors reviewed and edited the text. The authors declare no competing interests.

Funding Information:
We thank Cecilia Olsson, Pia Peterson, Jana Chmielniakova, Helene Leksell, Karin Staxäng, Monika Hodik, and the BioVis core for technical assistance at Uppsala University; Sonja Gustafsson, Byambajav Buyandelger, Elisabeth Raschperger, and the single-cell core at Campus Flemingsberg (SICOF) for technical assistance at Karolinska Institutet; and Karri Niiranen, Tanja Laakkonen, Tapio Tainola, the Flow Cytometry Unit at the Helsinki Institute of Life Sciences (HiLIFE), and the Laboratory Animal Center at HiLIFE for technical assistance at the University of Helsinki. We thank Drs. Mikio Furuse, Lydia Sorokin, and Philippe Soriano for kindly providing LSR antibodies, LAMA1 antibodies, and Pdgfra-H2BGFP mice, respectively. Financial support is acknowledged as follows: Swedish Research Council (C.B., 2015-00550 ; U.L., 2019:00285 ; T.M., 2020-02692 ); Swedish Cancer Society (C.B., 2018/449 , 2018/1154 , and 211714Pj ); Knut and Alice Wallenberg Foundation (C.B., 2020.0057 ; T.M., 2018.0218 ); Swedish Brain Foundation (C.B. and U.L., ALZ2019-0130 and ALZ2022-0005 ; U.L., F2020-0246 ); Erling-Persson Family Foundation (H.K., U.L., P.N., E.P.T., and C.B.); Stiftelsen för ålderssjukdomar vid KI (F.D.G., 2022:01310 ); Magn. Bergvalls Foundation (L.M., 2020-03735 , 2021-04275 , and 2022-158 ); Wenner-Gren foundations Fellows program (E.M.H.); Strategic Research Area Neuroscience (StratNeuro) (E.P.T.); Karolinska Institutet Funds (E.P.T., 2022-01576 ); Region Stockholm ALF (E.P.T., FoUI-962566 ); Region Stockholm Clinical Research Appointment (E.P.T., FoUI-981490 ); Karolinska Institutet Clinical Scientist Training Program (C.L.); Karolinska Institutet Research Internship (C.L.); Uppsala University Hospital Research Residency Program (C.L.); Strategic Research Area Stem Cells and Regeneration (StratRegen) (M.V.); KI Infrastructure Council (M.V.); The European Research Council (ERC) under the European Union's Horizon 2020 research and innovation programme under grant agreement No 743155 (BrainDrain) (K.A.); Research Council of Finland Terva Program (grant 335721) and the Finnish Brain Foundation (K.A.); Swiss National Science Foundation Grant 310030_189080 (B.E.) and CRSII5_213535 (S.P. and B.E); Research Council of Norway (RCN) Grant 214458 (L.H.B. and J.S.-M.); National Heart Lung and Blood Institute of the US National Institutes of Health (D.M., R01HL143896 , R01HL059157 , and R01HL127402 ). Computations/data handling were enabled by the National Academic Infrastructure for Supercomputing in Sweden (NAISS) and the Swedish National Infrastructure for Computing (SNIC) at NAISS AFFILIATED SITE/SNIC CENTRE, partially funded by Swedish Research Council through grant agreements 2022-06725 and 2018-05973 .

Publisher Copyright:
© 2023 The Author(s)

Citationsformater